Navigation Links
Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
Date:12/19/2007

Only Product of its Kind in Europe to Offer up to Six Months of Pain Relief

in OA Knee Pain

CAMBRIDGE, Mass., Dec. 19 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ) announced today that it has been granted European approval through a CE mark for Synvisc-One(TM), the single treatment of Synvisc(R) (hylan G-F 20) that has been shown in the European Union to provide up to six months of proven pain relief from osteoarthritis (OA) of the knee. Synvisc-One is now the only viscosupplementation product available in Europe that is labeled to provide this long-term duration of pain relief from a single injection.

Genzyme believes that Synvisc-One will simplify osteoarthritis pain management and provide added patient convenience, while reducing the overall cost of therapy associated with multiple injections and offering a treatment option that will expand the benefits of viscosupplementation to a broader number of patients.

"The European approval of Synvisc-One is based on positive clinical data which demonstrated that combining three doses of Synvisc in a single treatment is safe and effective in providing pain relief for up to six months in patients with knee osteoarthritis," stated Ann Merrifield, president of Genzyme Biosurgery, the business unit of Genzyme Corp. that manufactures and markets Synvisc. "Delivering the benefits of Synvisc through one treatment rather than three will provide additional options for physicians and their patients to reduce the cost and burden of multiple injections."

Genzyme will also pursue marketing approvals for Synvisc-One in wider geographies in Canada, Asia and Latin America based on the European CE mark approval.

Synvisc is currently deliver
'/>"/>

SOURCE Genzyme Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
2. Genzyme Begins Major Expansion of Boston Manufacturing Facility
3. Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share
4. Genzyme Receives Approval to Market Elaprase(R) in Japan
5. Genzyme Recognized by Scientists as a Top Employer
6. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
7. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
8. Genzyme Launches Cholestagel(R) in Europe
9. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
10. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
11. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... recent study by researchers at the University of ... physical mechanisms governing the interplay of spin and ... limits of ultrafast spintronic devices for data storage ... charge as well as spin-angular momentum. In a ... there is no spin current," explained David Cahill, ...
(Date:1/15/2014)... interface is the device," Nobel laureate Herbert Kroemer ... be found at the junctures where layers of ... nanotechnology, the interfaces between layers of metal oxides ... high-tech favorites as spintronics, high-temperature superconductors, ferroelectrics and ...
(Date:1/15/2014)... FALLS, N.Y., Jan. 15, 2014   Niagara Thermal Products ... selected by Buffalo BioBlower Technologies LLC ("B3") as the ... Phase 2 award from the Army Corps of Engineers.  ... that kills all biological contaminants and destroys VOCs and ...
(Date:1/15/2014)... California , January 15, 2014 Oxford ... today announced the appointment of Thomas C Reynolds MD, PhD ... years, development experience gained in the biotechnology industry, most recently ... am delighted to welcome Tom at this transformative time for ...
Breaking Biology Technology:University of Illinois study advances limits for ultrafast nano-devices 2A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... April 2 Bavarian Nordic, the,Danish-based biopharmaceutical company, recently ... the most significant matters in the report,as well as ... revenue for the year 2007 was DKK 332.1 million ... was in line with the Company,s,latest guidance. For 2008, ...
... KONG, April 2, 2008 /Xinhua-PRNewswire-FirstCall/ -- China,Technology ... or,"CTDC"), a provider of clean and renewable ... business in China, today announced that the,Company ... 5MW Thin Film,Amorphous Silicon Solar Module manufacturing ...
... Fla., April 1, 2008 MiMedx Group, Inc.,(OTC ... (OTC Bulletin,Board: AYXC), today reported that the contemplated ... Florida and related name change, to,MiMedx Group, Inc., ... 2008. As a result of the reverse split ...
Cached Biology Technology:Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 2Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 3Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 4Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 5Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 6Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 7Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 8Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process 9CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China 2CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China 3MiMedx Group Announces Post-split Name Change 2MiMedx Group Announces Post-split Name Change 3
(Date:7/10/2014)... centres around a family of enzymes known as heme ... in their active site. At the centre of the ... oxidised (ferryl) when a reacting heme is in an ... remained unanswered for decades is whether this oxidation involves ... (OH). Resolving this fundamental question has implications for understanding ...
(Date:7/10/2014)... Ore. Nuclear engineers at Oregon State University have ... device that should help people all over the world ... intensity, and whether or not it poses a health ... to public demand following the nuclear incident in Fukushima, ... what level of radiation they were being exposed to ...
(Date:7/10/2014)... For children and teens living with a cardiac pacemaker, ... decreased quality of life, reports a study in the ... , the official journal of the Society ... is published by Lippincott Williams & Wilkins , ... "Self-competence may function as a protective factor against lower ...
Breaking Biology News(10 mins):Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3Sophisticated radiation detector designed for broad public use 2Sophisticated radiation detector designed for broad public use 3For children with pacemakers, 'self-competence' affects quality of life 2
... available in Spanish . A research on ... the world, who recently died at the age of 114, ... contributed to this longevity. The research team, directed by Universitat ... healthy lifestyle, a Mediterranean diet, a temperate climate and regular ...
... have an important role to play in the fate of ... war campaigns, according to a new report in the May ... The researchers found evidence that fungi can lock ... likely to find its way into plants, animals, or the ...
... bubonic plague may be more virulent than their close relatives ... in the May issue of the journal Microbiology. The ... at body temperature. When there is no calcium available, it ... acid, said Professor Brubaker from the University of Chicago, USA. ...
Cached Biology News:The secret to long life may not be in the genes 2Fungi have a hand in depleted uranium's environmental fate 2
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
MAb to IgG2 (Fc gamma-2) IgG2 (Fc, gamma-2 epitope)...
... loading buffer is especially formulated for non-denaturing ... acids. The gel loading solution contains a ... add density and facilitate sample loading. EDTA ... require divalent cations and SDS has been ...
Biology Products: